e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of bronchodilator responses in patients with "irreversible" emphysema
O'Donnell D.E., Forkert L., Webb K.A.
Source:
Eur Respir J 2001; 18: 914-920
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O'Donnell D.E., Forkert L., Webb K.A.. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001; 18: 914-920
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004
Lung hyperinflation in COPD: the impact of pharmacotherapy
Source: Eur Respir Rev 2006; 15: 85-89
Year: 2006
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
Source: Eur Respir J 2004; 23: 832-840
Year: 2004
Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006
Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship?
Source: Eur Respir Rev 2006; 15: 68-71
Year: 2006
Asthma versus chronic obstructive pulmonary disease
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=195
Year: 2003
Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Physiology and consequences of lung hyperinflation in COPD
Source: Eur Respir Rev 2006; 15: 61-67
Year: 2006
Ventilatory and perfusion defects in chronic obstructive pulmonary disease (COPD) and response to bronchodilators
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
Bronchodilator-induced changes in dynamic hyperinflation but not in airway obstruction are associated with improvement in dyspnoea in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 174s
Year: 2001
Improving ventilatory mechanics
Source: Annual Congress 2005 - Contemporary physiological approaches to reversing the disease spiral in advanced COPD
Year: 2005
Dyspnoea
Source: Respipedia Article
Year: 2016
Spirometry to detect and manage chronic obstructive pulmonary disease and asthma in the primary care setting
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=1
Year: 2005
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?
Source: Eur Respir J 2012; 40: 322-329
Year: 2012
Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Prone position improves expiratory airway mechanics in severe chronic bronchitis
Source: Eur Respir J 2005; 25: 259-268
Year: 2005
FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 121s
Year: 2004
Regional ventilatory defects in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept